ArticleIn silico pharmacology2015

Use of in-silico assays to characterize the ADMET profile and identify potential therapeutic targets of fusarochromanone, a novel anti-cancer agent.

Madison Wynne El-Saadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.